Triple negative breast cancer (TNBC) is a variant of breast cancer that exhibits little to no expression of the HER2, progesterone receptor (PR), or estrogen receptor (ER) and is often correlated with poor prognosis due to limited treatment options (77). Here, ERBB2 is linked to breast carcinoma.